Clinical trial · Interventional
Evaluation of Initial High Risk Human Papillomavirus (HR-HPV) Viral Load as Predictive Marker for Cervical Intraepithelial Neoplasia Grade 1 (CIN1) Persistence
NCT00682552CI-TRIAL-00015489terminatedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Relationship between HPV infection and cervical cancer is well established. Among the HPV types identified to date, 15 are classified as high risk HPV (HR-HPV). Detection of HR-HPV has been proposed to optimize cervical cancer screening.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Intraepithelial Neoplasia | Cervical Intraepithelial Neoplasia | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| A cervico-vaginal cervical smear | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- 1
- description
- A cervico-vaginal cervical smear will be realized before every colposcopique examination. A new cervical taking for the search(research) and the detection of the HPV 16 and 18 will be realized.
- interventionNames
- Procedure: A cervico-vaginal cervical smear
Primary outcomes (1)
- measure
- The detection and the quantification of the DNA of the human oncogènes papillomavirus of type 16 and 18
- timeFrame
- 48 months
Secondary outcomes (1)
- measure
- The detection of the markers of the integration of the genome of the human oncogenes papillomavirus (targeted at the gene E2)
- timeFrame
- 48 months
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * The women whose last one FCV of screening put in evidence a LIEBG of the neck of the womb having been confirmed by the colposcopie. * The inclusive patients will be of more than 18 years old. All the patients will be profitable of a regime of Social Security. Exclusion Criteria: * The patients whose result of the colposcopie is clashing with that of the FCV of initial screening (normal collar, LIEHG or the other one). * The patients having an antecedent of DREGS of the neck of the womb, that this one was or not handled * The patients having had a hysterectomy. * The patients incapable to receive the information enlightened on the progress and the objectives of the study * The patients not having signed enlightened assent
References
Publications (0)
Data not yet available
No reference posted for this study.